Growth hormone controls lipolysis by regulation of FSP27 expression

Author:

Sharma Rita12,Luong Quyen12,Sharma Vishva M12,Harberson Mitchell12,Harper Brian12,Colborn Andrew12,Berryman Darlene E12,Jessen Niels345,Jørgensen Jens Otto Lunde46,Kopchick John J127,Puri Vishwajeet12,Lee Kevin Y12

Affiliation:

1. 1Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA

2. 2The Diabetes Institute, Ohio University, Athens, Ohio, USA

3. 3Research Laboratory for Biochemical Pathology, Aarhus University Hospital, Aarhus, Denmark

4. 4Department of Endocrinology and Internal Medicine, Aarhus University Hospital, Aarhus, Denmark

5. 5Department of Biomedicine, Aarhus University, Aarhus, Denmark

6. 6Medical Research Laboratory, Aarhus University, Aarhus, Denmark

7. 7Edison Biotechnology Institute, Ohio University, Athens, Ohio, USA

Abstract

Growth hormone (GH) has long been known to stimulate lipolysis and insulin resistance; however, the molecular mechanisms underlying these effects are unknown. In the present study, we demonstrate that GH acutely induces lipolysis in cultured adipocytes. This effect is secondary to the reduced expression of a negative regulator of lipolysis, fat-specific protein 27 (FSP27; aka Cidec) at both the mRNA and protein levels. These effects are mimicked in vivo as transgenic overexpression of GH leads to a reduction of FSP27 expression. Mechanistically, we show GH modulation of FSP27 expression is mediated through activation of both MEK/ERK- and STAT5-dependent intracellular signaling. These two molecular pathways interact to differentially manipulate peroxisome proliferator-activated receptor gamma activity (PPARγ) on the FSP27 promoter. Furthermore, overexpression of FSP27 is sufficient to fully suppress GH-induced lipolysis and insulin resistance in cultured adipocytes. Taken together, these data decipher a molecular mechanism by which GH acutely regulates lipolysis and insulin resistance in adipocytes.

Publisher

Bioscientifica

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3